Update on the treatment of Kawasaki disease in childhood

Area of Science:

• Pediatrics
• Immunology
• Cardiology

Background:

• Kawasaki disease (KD) is a critical pediatric illness affecting coronary arteries.
• Intravenous immunoglobulin (IVIG) has significantly improved KD management and prognosis.
• Current treatment guidelines suggest high efficacy, but concerns remain regarding coronary artery dilation.

Purpose of the Study:

• To evaluate the long-term effectiveness of IVIG in preventing coronary artery abnormalities in KD.
• To explore the incidence of coronary artery dilation despite prompt IVIG therapy.
• To investigate the need for alternative or adjunct therapies for acute and recurrent KD.

Main Methods:

• Review of echocardiographic data adjusted for body size in KD patients.
• Analysis of long-term outcomes following standard IVIG treatment.
• Consideration of chronic endothelial function alterations post-KD.

Main Results:

• Echocardiographic data suggest a higher incidence of coronary artery dilation than previously reported, even with prompt IVIG.
• Chronic alterations in endothelial function are observed in KD survivors.
• The 95% effectiveness rate may not fully capture the long-term vascular impact.

Conclusions:

• Despite IVIG's benefits, more effective management strategies for Kawasaki disease are required.
• Adjunct therapies, such as high-dose corticosteroids, are under investigation to improve long-term outcomes.
• Further research is crucial to optimize the treatment of acute and recurrent KD and prevent lasting cardiovascular complications.